Exondys 51 (eteplirsen) for the Treatment of Duchenne Muscular Dystrophy (DMD)

Exondys 51 (eteplirsen) is an injectable solution developed by Sarepta Therapeutics.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals